Aerie Pharmaceut Stock Price, News & Analysis

AERI NASDAQ

Company Description

Aerie Pharmaceut (NASDAQ: AERI) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.

AERI stock has gained 48.5% over the past year.

This page provides a comprehensive overview of AERI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+48.49%

Performance 1 year

$0.0

Market Cap

49.4M

Shares outstanding

Aerie Pharmaceut (AERI) stock. Over the past 12 months, the stock has gained 48.5%.

Latest News

View All

November 22, 2022

0.00%

Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business

acquisition

November 3, 2022

-0.07%

Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results

earnings

September 13, 2022

0.00%

Aerie Pharmaceuticals to Host Key Opinion Leader Event on Dry Eye Disease: Current Landscape, Unmet Needs, and Emerging Treatment Options

conferences

August 23, 2022

+35.96%

Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio

acquisition

August 15, 2022

+1.47%

Aerie Pharmaceuticals Announces New Employee Inducement Grant

management

August 4, 2022

+20.90%

Aerie Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update

earnings

Aerie Pharmaceut has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include acquisition, earnings, conferences, management. View all AERI news →

SEC Filings

View All

No SEC filings available for AERI.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

AERI Company Profile & Sector Positioning

Aerie Pharmaceut (AERI) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.